ABSTRAm. To evaluate the possible role of various hormones on fetal pancreas development, late gestational fetal rat pancreata (20 days) were cultured in a serum-free medium for 6 days in the presence of cholecystokininoctapeptide (CCK-8), epidermal growth factor, triiodothyronine, or glucagon with or without dexamethasone. In the absence of any added hormone, the tissue amylase activity declined very rapidly. Epidermal growth factor alone (4. M) could not preserve the amylase activity, whereas triiodothyronine (0.1 pM) and glucagon (4 pglml) had a deleterious effect that was prevented by the addition of DXM (3. M). In the presence of CCK-8 (2. lo-" M) 50 and 30% of the amylase activity was maintained on the 2nd and the 4th day of culture, respectively. The CCK-8 effect was dose dependent and was inhibited by asperlicin (10 pM). The combination of CCK-8 and dexamethasone maintained more than 80% of the amylase activity in the fetal pancreas explants through 4 days of culture. Fetal pancreas cultured in this optimal medium and treated with streptozotocin (lo-' M) during the 1st day of culture showed a significantly lower tissue amylase activity on the 4th and 6th days than those not treated with streptozotocin. The streptozotocin effect was attenuated when insulin (0.1 U/ml) was added. These data suggest that, in addition to the well-known effect of glucocorticoid on enzyme activities in the fetal pancreas, two additional hormones, CCK and insulin, could play a role in the modulation of pancreatic amylase activity in the fetal rat. (Pediatr Res 23: 539-542, 1988 Abbreviations CCK, cholecystokinin EGF, epidermal growth factor DXM, dexamethasone SFM, serum-free medium BSA, bovine serum albumin CCK-8, CCK-octapeptide T3, triiodothyronine ASA, amylase-specific activity
In the rat, the development of the exocrine pancreatic enzymes has been shown to be a three-phase process (1) . The primary transition (day 10 of gestation) leads to the accumulation of very low specific activities of exocrine enzymes without any zymogen granules. Then, according with the appearance of the granules, the activities of exocrine enzymes start to increase dramatically at day 15 of gestation. Finally, shortly after birth, the third phase leads to a decrease of most of the enzymes. The role of hormones in these perinatal changes was first suggested by the fact that the pancreatic mass of newborn rats was decreased by decapitation in utero (2) . In vivo experiments have shown that hydrocortisone and CCK increased the amylase-specific activity in the term fetal pancreas (3-3, whereas thyroxine and glucagon did not modulate this enzyme at the same developmental stage (3) . These in vivo studies have several disadvantages, i.e. the effect of the placental bamer and the possible complication of mother-fetus interaction during the experiments. To bypass these pitfalls, several groups developed in vitro models that enabled them to show that corticosteroids (but not gonadal steroids) increased the amount of enzymes in cultured fetal pancreata but did not precociously induce their appearance (6) (7) (8) . Later in gestation, corticosteroids prevented the decline in amylase and acinar cells that usually occurs in pancreatic rudiments placed in culture at that time (8, 9) . To our knowledge there is no report on a comprehensive study with other hormones that are known to affect the pancreatic development. The aim of this study was to test the effect on prenatal pancreatic development of hormones that have been proven to modulate the amylase activity in the adult, such as CCK (10) and glucagon (1 1), or in the developing rat, such as thyroid hormones (12) , CCK (13) , and EGF (14) .
Pancreatic rudiments were cultured in a chemically defined medium to test the possible direct effect of these hormones when added singly to the medium. Their ability to modulate the effect of glucocorticoids was also evaluated by monitoring their effects in combination with DMX. Furthermore, despite the fact that the addition of insulin was shown to have no effect on amylase activity in cultured fetal pancreas (15) , the role of endogenous insulin was further examined by using streptozotocin to suppress insulin production by the explants.
MATERIALS AND METHODS
Animals. Sprague-Dawley male and female rats were mated Received September 14, 1987 ; accepted January 20, 1988. and the next morning the females were checked for the presence and fetuses were removed. During the time of fetus dissection, the pancreata were pooled in a Petri dish containing 4 ml of SFM at room temperature. The pancreata were then carefully cut into 0.5 mm3 explants and randomly distributed into different dishes for cultures.
Media. The SFM consisted of 50% Dulbecco modified Eagle medium (GIBCO, Grand Island, NY) and 50% RPMI 1640 (GIBCO), with HEPES pH 7.4-25 mM (USBC, Cleveland, OH), penicillin 50 U/ml + streptomycin 50 pg/ml (GIBCO), and BSA 2 mg/dl (Sigma Chemical Co., St. Louis, MO). Stock solutions were prepared for additive products, kept at -20" C, and used at the following final concentrations: Asperlicin 10 pM, kindly provided by Dr. R. Chang, Merck & Co., Inc., West Point, PA, CCK-8 2. lo-" M, Research Plus, Inc., Bayonne and Dennville, NJ; DXM 3.
M, Sigma streptozotocin lo-' M, Sigma; and T3 0.1 pM, Sigma. Stock solutions for DXM and asperlicin were prepared in ethanol.
Cultures. Petri dishes containing nine to 12 pancreatic fragments suspended in 3 ml of medium were incubated at 37" C in a humid atmosphere of 5 % C02 in air. During the culture period, the media were chahged daily. Three or four pancreatic fragments were withdrawn at day 2,4, and 6 of culture. They were sonicated in 100 p1 of water and stored at -80" C. At day 6 of culture, all the samples were thawed and assayed for amylase and protein.
When streptozotocin was used, it was present in the medium only on the 1st day of culture.
Assays. Protein was determined by the technique of Lowry et al. (16) using BSA fraction V as the standard. Amylase was measured using the Phadebas amylase test from Pharmacia (Piscataway, NJ).
Calculations. Specific activities were calculated and normalized relative to that found at day 0 of culture which was taken as the 100% value. Values are reported as means 2 SD with significance determined by the Student's t test (two-tailed). days of culture, the ASA was already less than 20% of the starting value, and further declined thereafter. The addition of CCK-8 to the SFM (Fig. 1 B) allowed a significantly better maintenance of the ASA, at least for the first 4 days of culture. This effect was lost on day 6. In the presence of EGF (Fig 1 C) , the ASA was not different from that in SFM cultures. T3 and glucagon ( Fig. 1D and E, respectively), however, had a deleterious effect on the tissue amylase activity after 4 days of culture.
Cultures with DXM. In the presence of DXM, the maintenance of the amylase activity was much better than in SFM alone (compare columns A in Figs. 1 and 2 ). Almost 50% of the initial ASA was maintained during the first 4 days of culture with glucocorticoid. Ethanol alone, in the same concentration as that used with DXM, had no effect on the cultures (data not shown). The best results were obtained when CCK-8 was added to the DXM-containing medium (Fig. 2B) . CCK-8 and DXM together maintained more than 80% of the starting ASA during 4 days of culture and it was still more than 60% on day 6. In some cultures, this CCK-&DXM combination induced an increase of ASA on day 2. In contrast, none of the three other hormones tested (EGF, T3, glucagon) significantly change the effect of DXM on the ASA in the cultured fetal pancreata. Glucagon still reduced the tissue amylase activity in the presence of DXM but not significantly.
Dose-response effect of CCK-8. Despite the fact that the CCK-8 concentration used in the cultures was in a range known to be effective in stimulating adult pancreatic acinar cell growth (17), we did not know if this was also true for the fetal pancreas. The dose-response curve (Fig. 3) showed that the effect of CCK-8 on the maintenance of ASA in fetal pancreas after 2 days of culture was dose-dependent with a maximum occumng between 10-l2 and lo-'' M. Inhibition of the CCK-8 effect. When asperlicin, a potent CCK inhibitor (18) , was added to the cultures camed out in the optimal medium (containing CCK-8 and DXM), the effect of CCK-8 on ASA was suppressed ( Table 1) . The enzyme activities were reduced to a level close to that obtained with DXM alone.
Effect ofstreptozotocin. When cultures (containing CCK-8 and DXM),were exposed to streptozotocin for 1 day, a significant decrease of the ASA was found subsequently on days 4 and 6 of culture, as compared to those levels found in the absence of streptozotocin in the same media (Table 2 ). This difference was corrected when in the same protocol insulin was present throughout the entire period of culture.
DISCUSSION
The dramatic rise in the enzymatic activities that occurs on day 15 of gestation in the fetal rat pancreas seems to be mainly genetically determined, as shown by the ability of the pancreas to differentiate in culture (19) . Yet exogenous factors, such as hormone, have been shown to play a role in this process (see Ref. 1 for review). Herein, we were able to show that, in addition to the well-known effect of glucocorticoid, other hormones could modulate the enzyme activities in the late fetal exocrine pancreas, at least in vitro.
Inasmuch as EGF has been shown to increase the enzyme activities in the brush-border of the fetal mouse small intestine (20) , its possible role on another organ of the digestive tract at the same developmental stage was intriguing. Furthermore, a study in our laboratory showed that the fetal pancreas had a high capacity for EGF binding (21) . Nevertheless the physiological relevance of these observations remained uncertain because no significant EGF transfer through the placenta could be demonstrated in the late gestational period in the rat (21) . In the current study, EGF had no effect on ASA in cultured fetal rat pancreas with or without DXM (Figs. 1 and 2, C) . This fact does not rule out a possible trophic effect of EGF on the fetal pancreas, but points out that if present, it does not act on the exocrine enzyme activities.
Other studies in our laboratory have shown that thyroxin induces a precocious postnatal pancreatic development, in terms of enzyme activities (22), but also has an indirect effect by .t Indicates significant differences in comparison to controls; t p < 0.05.
increasing the glucocorticoid binding capacity of the acinar cells (22, 23) . Herein T3 was used because it is the active hormone. T3 did not enhance the effect of DXM on the ASA in the fetal pancreas cultures (Fig. 2) . These results suggest that the mechanisms involved in the T3-DXM interaction later in development are not mature in the fetal pancreas. When used alone in the SFM, T3 quickened the decrease of ASA, as did glucagon (Fig.  1 ).
An important finding in our experiments was that involving CCK-8. This hormone was previously shown to have trophic effects on the adult rat pancreas in vivo (10) as well as in vitro (17) . Recently, Werlin and Stefaniak (5) have shown that injections of CCK-8 in pregnant rats enhanced the ASA in the fullterm pancreas. Unfortunately, the authors could not conclude whether these results were secondary to effect on the mother or direct effects of the hormone on the fetus. In our in vitro study, CCK-8 by itself significantly reduced the decrease of ASA that is normally observed when fetal pancreas is cultured in a hormonefree medium at a late gestation stage (Fig. 1B) . The effect of CCK-8 was dose dependent, with an optimum between lo-" and 10-lo M (Fig. 3) . This dose-dependent effect in vitro with a significant drop in effect at the highest concentrations matched the results of Werlin and Stefaniak (5) who obtain higher ASA in the term fetal pancreas when the pregnant rats were injected with a CCK-8 dose of 2.5 &kg than when they were injected with 10 pg/kg. This may indirectly support the interpretation that the CCK-8 effect in vivo is a direct action of the hormone on the fetal pancreas. In our culture system, a combination of CCK-8 and DXM (Fig. 2B ) allowed a nearly complete maintenance of the ASA during the first 4 days of culture. A comparison of the results obtained with the CCK-8 alone (Fig. 1 B) the DXM alone (Fig. U ) , or the CCK-&DXM combination (Fig. 2B) shows that the action of both hormones was different, because an additive but not synergistic effect was seen. These results also suggest that CCK-8 is able to act directly on the fetal pancreas.
an additive but not synergistic effect was seen. These results also suggest that CCK-8 is able to act directly on the fetal pancreas.
How CCK-8 acts on the fetal acinar cell still remains unclear. Previous studies have suggested that the unresponsiveness of the term fetal rat pancreas to secretagogue stimulation was related to the low binding capacity of the receptors, whereas the underlying machinery of the stimulus-secretion coupling was already mature (24, 25) . However, it was suggested in a recent report (26) , that the fetal and the neonatal rat pancreas had the same binding capacity to CCK-8. The difference in responsiveness to CCK-8, in terms of amylase release, was viewed as related to an immaturity of the signal transduction events distal to calcium mobilization. In the present study, we have shown that whereas CCK-8 did not stimulate amylase release in the fetal pancreas (data not shown) it already had an effect on the tissue amylase at this age. Furthermore, because the CCK-8 effect could be inhibited by asperlicin, a potent CCK-8 antagonist that interacts competitively with the CCK receptors (1 8), our data suggest also that the membrane binding of CCK-8 is already present in the fetus. Further, the pathway leading to the trophic effect that is present at this stage is in contrast to those pathways for the stimulus-secretion coupling process that are immature at the same stage.
The role of insulin on the exocrine pancreas in the rat in vivo has been shown by other authors (1 1). This hormone is also indispensable in the maintainance of rat adult acinar cells (17) , or fetal pancreata (19) for a long time in vitro. Previously we have shown that neonatal streptozotocin-induced diabetes in rat resulted in a transient drop of amylase activity (27) . This effect was partially attenuated by insulin supplementation. Inasmuch as insulin was shown to be secreted very early in the fetal rat (28), the possible presence of a functioning P-cell-acinar-cell axis at this stage was intriguing. Our results (Table 2) showed that after 4 days, the ASA was significantly lower in the fetal pancreata cultured after a 24-h initial exposure to streptozotocin. The fact that insulin can abolish the effect of streptozotocin, which has been shown to damage P-cells in vitro (29) , suggests that this hormone plays a role in the prenatal amylase synthesis by the acinar cells. As reported by Sanders and Rutter (I 5) with similar doses, insulin in our system (data not shown) did not modulate the enzymatic activities of cultured fetal pancreata. However, in the study by Sanders and Rutter (lS), they were not able to show any effect of antiinsulin antiserum in the medium. It can be speculated that the effect of insulin on the acinar cells is a paracine effect that works at its optimal level in the whole pancreas and that antiinsulin antiserum were unable either to bind all the insulin molecules or to mask the active sites of the hormone.
In conclusion, we have shown herein that in addition to glucocorticoids, two other hormones, CCK and insulin, are required to maintain the amylase activity in the fetal exocrine pancreas in vitro. However, before accepting the physiological relevance of the CCK effect, an intestinal secretion of this hormone in the fetal rat, or its possible transfer through the placenta, have to be further demonstrated.
